Justin Moser, MD
Internal Medicine · Scottsdale, AZNPI 1891133989
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,505 of the $54,604 with a category attached, or 74.2%. 10 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 27.6% of the total. 2025 is the largest year on record at $20,778, 8.9 times the $2,338 reported in 2020. Among internal medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $866.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$15K
- Immunocore Limited$11K
- Sun Pharmaceutical Industries Inc.$9K
- Incyte Corporation$8K
- Iovance Biotherapeutics, Inc.$6K
- Array Biopharma Inc$2K
- plus $2K from 4 others
Across 380 payments — averaging $10,026 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$1.4M
- Merck$1.1M
- Sanofi US Services Inc.$372K
- Genentech, Inc.$341K
- Novocure Inc.$282K
- Y-mabs Therapeutics, Inc.$218K
- plus $111K from 4 others
What the payments were for
- Consulting fees$40,50574%
- Speaking & faculty fees$7,81014%
- Travel & lodging$4,8399%
- Food & beverage$1,4513%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 10 | $15,077 |
| Immunocore Limited | 19 | $11,488 |
| Sun Pharmaceutical Industries Inc. | 8 | $9,195 |
| Incyte Corporation | 9 | $8,416 |
| Iovance Biotherapeutics, Inc. | 8 | $6,163 |
| Array Biopharma Inc | 2 | $2,300 |
| Caris MPI, Inc. | 4 | $1,690 |
| Sanofi | 1 | $189 |
| Trisalus Life Sciences, Inc. | 1 | $45 |
| Adaptimmune LLC | 1 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,604 in reported general payments places this provider in the 95th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 30 | $144 |
| Prednisone | 16 | $123 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Scottsdale
- Jacque SokolovScottsdale$235K
- Jason BondScottsdale$104K
- Nazila BiriaScottsdale$18K
- Douglas LakinScottsdale$14K
- Brittany HinesScottsdale$12K
- Frank LovecchioPhoenix$911K
- Nasser HajaigPhoenix$687K
- Rajesh JanardhananTucson$685K
- Mona SelejTucson$440K
- Kelly KrohnPhoenix$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.